Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 1,036.16 | 1,169.17 | 1,176.03 | 1,234.69 | 1,016.48 |
| Operating profit | 113.76 | 137.33 | 124.91 | 174.78 | 143.40 |
| Interest | 14.63 | 15.32 | 15.06 | 10.84 | 9.22 |
| Gross profit | 99.62 | 123.40 | 110.18 | 166.18 | 136.71 |
| EPS (Rs) | 6.28 | 8.06 | 6.80 | 11.75 | 9.30 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 0.49 | 1.39 | 0.33 | 2.24 | 2.53 |
| Stock adjustment | 13.50 | -15.90 | -75.06 | -25.77 | -52.17 |
| Raw material | 652.61 | 790.99 | 865.59 | 824.67 | 700.12 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 40.81 | 40.70 | 34.74 | 35.67 | 33.65 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 215.48 | 216.05 | 225.85 | 225.34 | 191.48 |
| Provisions made | - | - | - | - | - |
| Depreciation | 23.57 | 23.53 | 23.75 | 23.83 | 23.56 |
| Taxation | 18.75 | 25.75 | 23.50 | 33.50 | 27.00 |
| Net profit / loss | 57.30 | 74.12 | 62.93 | 108.85 | 86.15 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 91.27 | 91.94 | 92.60 | 92.60 | 92.60 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.98 | 11.75 | 10.62 | 14.16 | 14.11 |
| GPM (%) | 9.61 | 10.54 | 9.37 | 13.43 | 13.42 |
| NPM (%) | 5.53 | 6.33 | 5.35 | 8.80 | 8.45 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis